Baird Financial Group, Inc. Maravai Lifesciences Holdings, Inc. Transaction History

Baird Financial Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$24.46 - $40.92 $350,976 - $587,161	-14,349 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$35.0 - $45.94 $713,160 - $936,073	-20,376 Reduced 58.68%	14,349 $601,000
Q3 2021 Nov 12, 2021	SELL	$36.8 - $60.62 $535,992 - $882,930	-14,565 Reduced 29.55%	34,725 $1.7 Million
Q2 2021 Aug 11, 2021	BUY	$32.46 - $45.0 $354,268 - $491,130	10,914 Added 28.44%	49,290 $2.06 Million
Q1 2021 May 13, 2021	BUY	$25.8 - $38.49 $990,100 - $1.48 Million	38,376 New	38,376 $1.37 Million

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $723M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.